Essential Pharma - Crunchbase Company Profile & Funding

Q: Who invested in Essential Pharma?

Essential Pharma has 2 investors including Carlyle AlpInvest And Sixth Street.

Q: When was the last funding round for Essential Pharma?

Essential Pharma closed its last funding round on obfuscated from a Private Equity round.

Q: How much funding has Essential Pharma raised to date?

Essential Pharma has raised obfuscated.

Overview

Essential Pharma

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Essential Pharma

CB Rank

44021

Essential Pharma is a specialty pharma firm that offers clinically differentiated, niche medicines in small patient population

Acquired by

Gyrus Capital

Founded

obfuscation

Private

Private Equity

Egham, Surrey, United Kingdom

101-250

essentialpharmagroup.com/

Consulting

Medical

Pharmaceutical

Funding Rounds

Private Equity

OBF

obfuscation

Key People

Liz Holmes: CMO
Emma Johnson: Chief Executive Officer
Past Role: EUSA Pharma, Co-Founder and Chief Financial Officer

Details

Legal Name

Essential Pharma Limited

Also Known As

Essential Pharma Group

Operating Status

Active

Company Type

For Profit

About the Company

Essential Pharma (EP) ensures the sustainable supply of low volume, difficult to manufacture but clinically well-established pharmaceutical products to patients. These branded and generic medicines form an essential part of the pharmacopeia and represent many therapeutic areas. The company is an important partner to healthcare providers by

providing medicines that otherwise would not be available.

Phone Number

+44 (0)1784 477167

Contact Email

info@essentialpharmagroup.com

Predictions & Insights

Growth Insight

See this Growth Insight

Essential Pharma is

Lorem

to be growing

Top Contributing Factors

Merger or Acquisition

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

Hu14.18K322A (Hu14.18)

A humanized anti-GD2 antibody immunotherapy for treating high-risk neuroblastoma in children.

Amiloride

A medication used to treat conditions such as hypertension and edema by acting as a potassium-sparing diuretic.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Private Equity Round - Essential Pharma	2	obfuscated obfuscation	Carlyle AlpInvest	Private Equity
obfuscated obfuscation	Private Equity Round - Essential Pharma	2	obfuscated obfuscation	Carlyle AlpInvest	Private Equity
obfuscated obfuscation	Private Equity Round - Essential Pharma	2	obfuscated obfuscation	Carlyle AlpInvest	Private Equity
obfuscated obfuscation	Private Equity Round - Essential Pharma	2	obfuscated obfuscation	Carlyle AlpInvest	Private Equity
obfuscated obfuscation	Private Equity Round - Essential Pharma	2	obfuscated obfuscation	Carlyle AlpInvest	Private Equity

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Private Equity Round - Essential Pharma	2	obfuscated obfuscation	Carlyle AlpInvest	Private Equity
obfuscated obfuscation	Private Equity Round - Essential Pharma	2	obfuscated obfuscation	Carlyle AlpInvest	Private Equity
obfuscated obfuscation	Private Equity Round - Essential Pharma	2	obfuscated obfuscation	Carlyle AlpInvest	Private Equity
obfuscated obfuscation	Private Equity Round - Essential Pharma	2	obfuscated obfuscation	Carlyle AlpInvest	Private Equity
obfuscated obfuscation	Private Equity Round - Essential Pharma	2	obfuscated obfuscation	Carlyle AlpInvest	Private Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Carlyle AlpInvest	Yes	Private Equity Round - Essential Pharma	—
Carlyle AlpInvest	Yes	Private Equity Round - Essential Pharma	—
Carlyle AlpInvest	Yes	Private Equity Round - Essential Pharma	—
Carlyle AlpInvest	Yes	Private Equity Round - Essential Pharma	—
Carlyle AlpInvest	Yes	Private Equity Round - Essential Pharma	—